Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 7 de 7
Filtrer
Plus de filtres











Base de données
Gamme d'année
1.
Neoplasma ; 64(4): 633-639, 2017.
Article de Anglais | MEDLINE | ID: mdl-28485172

RÉSUMÉ

Farnesoid X Receptor (FXR), a nuclear receptor superfamily member, is related with bile acids, glucose and lipids metabolism and recently with cancer. In the present study the clinical significance of FXR expression in invasive breast carcinoma was evaluated. FXR protein expression was assessed immunohistochemically on paraffin-embedded breast cancer tissues obtained from 115 breast cancer patients and was statistically analyzed with clinicopathological parameters, estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2) expression, as well as with tumor cells' proliferative capacity and overall and disease-free patients' survival. FXR positivity was noted in 91 (79.1%) and high FXR expression in 51 (44.3%) out of 115 invasive breast carcinoma cases. High FXR expression was significantly associated with smaller tumor size (p=0.0318) and increased tumor cells' proliferative rate (p=0.0375). Invasive breast carcinoma patients presenting high FXR expression showed significantly longer overall and disease-free survival times compared to those with low FXR expression (log-rank test, p=0.0052 and p=0.0058). In multivariate analysis, FXR expression was identified as independent prognostic factor of overall and disease-free patients' survival (Cox-regression analysis, p=0.0023 and p=0.0049, respectively). The present data support evidence that FXR may be implicated at the earlier stage of breast malignant disease progression, being a strong and independent prognosticator of favorable overall and disease-free survival in invasive breast carcinoma.


Sujet(s)
Tumeurs du sein/métabolisme , Récepteurs cytoplasmiques et nucléaires/métabolisme , Marqueurs biologiques tumoraux/métabolisme , Tumeurs du sein/diagnostic , Survie sans rechute , Femelle , Humains , Pronostic , Récepteur ErbB-2/métabolisme , Récepteurs des oestrogènes/métabolisme , Récepteurs à la progestérone/métabolisme
2.
Clin Exp Obstet Gynecol ; 43(6): 849-852, 2016.
Article de Anglais | MEDLINE | ID: mdl-29944236

RÉSUMÉ

PURPOSE: To study the expression of hormonal receptors, collagen, elastin, proteoglycans, and VIP in the vaginal wall of women with stress urinary incontinence (SUI). MATERIALS AND METHODS: Fifty-eight specimens of the anterior vaginal wall (28 women with SUI) were processed by Ventana immunostaining method. RESULTS: Both groups were compatible for age, BMI, and obstetric history. Positive ER-α and ER-ß immunoreaction was observed in 46.4% and 3.6% of SUI (43.3% and 33.3% of controls) (p < 0.05), respectively, and PR immunoreaction in 39.3% of SUI (46.7% of controls). Collagen I and III immunoreaction was observed in 28,6% and 21.4% of SUI (30.% and 36.7% of controls), respectively, and elastin, decorin, and fibromodulin immunoreaction in 10.7%, 10.7%, and 10.7% of SUI (50%, 33.3%, 33,.3% of controls) (p < 0.05), respectively. VIP immunoreaction was observed in 7.1% of SUI (36.7% of controls). CONCLUSION: Imunoexpression of ER-P, elastin, decorin, fibromodulin, and VIP was significantly lower in SUI than controls, showing that the ER-ß dependent re-modeling of the extracellular matrix of vaginal tissues is the main mechanism of SUI.


Sujet(s)
Collagène/métabolisme , Élastine/métabolisme , Récepteur alpha des oestrogènes/métabolisme , Récepteur bêta des oestrogènes/métabolisme , Protéoglycanes/métabolisme , Incontinence urinaire d'effort/métabolisme , Vagin/métabolisme , Sujet âgé , Études cas-témoins , Collagène de type I/métabolisme , Collagène de type III/métabolisme , Décorine/métabolisme , Femelle , Fibromoduline/métabolisme , Humains , Immunohistochimie , Adulte d'âge moyen , Récepteurs à la progestérone/métabolisme , Incontinence urinaire d'effort/chirurgie , Peptide vasoactif intestinal/métabolisme
3.
Anat Histol Embryol ; 36(6): 433-6, 2007 Dec.
Article de Anglais | MEDLINE | ID: mdl-18021353

RÉSUMÉ

Sarcomas are neoplasms of mesenchymal origin, with a predominant cell population mimicking the organization of various soft tissues and/or bones. Previous categorizations also included the possibility of the presence of tissue macrophage-like (histiocytes) neoplasm cells, in a tumour described as malignant fibrous histiocytoma, but this group has been considered as a variety of undifferentiated pleomorphic sarcomas. Although this kind of malignancy is not rare in humans, only few cases have been reported in laboratory animals. We report an unusual single case of spontaneous tumour growth, detected by casual observation, in the left thoracic area of an 18-month-old male laboratory Wistar rat. Both this individual and his ancestors were not exposed to any known carcinogenic substance or radiation, thus suggesting the development of the neoplasm as a spontaneous event. The mass was extracted surgically under general anaesthesia, and slices were examined histologically and immunohistochemically, using photon microscopy. The pathologist reported the presence of a combination of fibroblasts and undifferentiated mesenchymal cells arranged in a storiform pattern. Immunohistochemistry was performed on the tissue using specific antibodies for several proliferation (Ki-67) and differentiation (S-100, CD-34, CD-68, pan-keratin, desmin and smooth muscle actin-SMA) markers. Positive reaction was observed for S-100, Ki-67, CD-68, desmin and SMA (limited) but not for CD-34 or cytokeratin.


Sujet(s)
Rat Wistar , Maladies des rongeurs/anatomopathologie , Sarcomes/médecine vétérinaire , Tumeurs du thorax/médecine vétérinaire , Animaux , Immunohistochimie/médecine vétérinaire , Mâle , Rats , Maladies des rongeurs/chirurgie , Sarcomes/anatomopathologie , Sarcomes/chirurgie , Tumeurs du thorax/anatomopathologie , Tumeurs du thorax/chirurgie
4.
J Steroid Biochem Mol Biol ; 78(5): 401-7, 2001 Nov.
Article de Anglais | MEDLINE | ID: mdl-11738550

RÉSUMÉ

Steroid/thyroid actions in the brain are exerted through their receptors which belong to the nuclear receptor superfamily. Transcriptional transactivation mediated by these receptors depends on recruited co-activators, among which steroid receptor co-activators (SRCs) seem to be restricted to the nuclear receptor family. By using Northern and Western blot analysis we have estimated the mRNA and protein levels, respectively, of SRC-1 in the brain and pituitary of male and female rats, under physiological conditions and following restraint stress. Under basal conditions, SRC-1 is expressed at higher levels in the hippocampus and the pituitary of male, compared to female rats. Acute stress results in decreased, compared to the control, SRC-1 levels in the hypothalamus of both sexes, in the pituitary and frontal cortex of male rats, and in increased SRC-1 levels in the hippocampus of female rats. The observed changes at the mRNA level are supported by analogous changes at the protein level. The apparent regulation of SRC-1 gene expression in the nervous system by the endocrine status of the animal, adds another level of complexity in the mechanism controlling steroid hormone actions. Furthermore, the variability in SRC-1 expression within the brain provides a means to explain the cell-specificity of steroid hormone actions in this tissue.


Sujet(s)
Encéphale/métabolisme , Hypophyse/métabolisme , Récepteurs aux stéroïdes/métabolisme , Facteurs de transcription/génétique , Facteurs de transcription/métabolisme , Animaux , Cortex cérébral/métabolisme , Femelle , Régulation de l'expression des gènes , Hippocampe/métabolisme , Histone acetyltransferases , Hypothalamus/métabolisme , Mâle , Coactivateur-1 de récepteur nucléaire , ARN messager/génétique , ARN messager/métabolisme , Rats , Rat Wistar , Caractères sexuels , Stress physiologique/génétique , Stress physiologique/métabolisme
5.
Neuroendocrinology ; 71(6): 343-53, 2000 Jun.
Article de Anglais | MEDLINE | ID: mdl-10878496

RÉSUMÉ

The two subtypes of corticosterone receptors in the rat brain play a pivotal role in the modulation of the stress response. Appropriate control of their gene expression is therefore critical for the maintenance of cellular and organism homeostasis. In this study, we investigated the contribution of gender and of the cellular environment of certain brain areas to the expression of both types of corticosteroid receptors, following restraint stress. Adult Wistar rats of both sexes were subjected to acute, chronic or to a combined chronic plus acute stress regimen, and the expression of glucocorticoid and mineralocorticoid receptors was evaluated in their hippocampus, hypothalamus, pituitary and frontal cortex, by using Northern blot analysis. Significant sex differences were observed in the first three brain areas examined as to the stress-induced expression of corticosteroid receptors. Among these, females showed a distinct mechanism of regulating glucocorticoid/mineralocorticoid receptor ratio in the hippocampus upon chronic stress, while the female hypothalamus was more prone than the male to changing corticosteroid receptor expression in response to restraint stress. In another set of experiments, we assessed the influence of ovarian steroids on stress-induced corticosteroid receptor expression in the above brain areas by analyzing ovariectomized rats exposed to short-term restraint. Our results showed that although ovarian steroids affect the stress-induced expression of receptor genes in a region-specific manner, their elimination does not appear to lead to the male pattern of expression. These findings provide further evidence for the existence of both regional and gender specificity in the regulation of brain and pituitary corticosteroid receptors following stress, and support the hypothesis of a distinct male and female neuroendocrine axis in response to stress.


Sujet(s)
Chimie du cerveau/physiologie , Encéphale/cytologie , Récepteurs aux stéroïdes/métabolisme , Stress psychologique/métabolisme , Glandes surrénales/anatomopathologie , Glandes surrénales/physiologie , Animaux , Technique de Northern , Corticostérone/sang , Femelle , Hypothalamus/croissance et développement , Hypothalamus/physiologie , Mâle , Taille d'organe/physiologie , Ovariectomie , Dosage radioimmunologique , Rats , Rat Wistar , Récepteurs aux glucocorticoïdes/biosynthèse , Récepteurs des minéralocorticoïdes/biosynthèse , Contention physique , Caractères sexuels , Stress psychologique/anatomopathologie , Facteurs temps , Perte de poids/physiologie
6.
Pathol Res Pract ; 196(5): 313-9, 2000.
Article de Anglais | MEDLINE | ID: mdl-10834388

RÉSUMÉ

Metallothioneins (MT), a group of ubiquitous low molecular weight proteins, implicated primarily in metal ion detoxification, are known to be expressed during hepatocellular proliferation after partial hepatectomy in rats. In the present study, we investigated the expression of MT in a rat model of liver injury and regeneration, induced by intraperitoneal administration of thioacetamide (TAA). The animals were killed at 0, 12, 24, 36, 48, 60, 72, 84, 96, 108 and 120 hours after TAA administration. The rate of tritiated thymidine incorporation into hepatic DNA, the enzymatic activity of thymidine kinase, and the assessment of the mitotic index in hepatocytes were used as indices of liver regeneration. Liver MTs were detected immunohistochemically. TAA administration caused severe hepatic injury, followed by regeneration. MT expression became prominent in hepatocytes as early as 12 hours post-TAA administration. At 24 and 36 hours post-TAA administration intense nuclear and cytoplasmic staining of hepatocytes was found in the vicinity of necrotic areas. The maximal nuclear and cytoplasmic MT expression coincides with the peak of hepatocyte proliferative capacity, occurring at 48 and 60 hours post-TAA administration. MT expression correlated positively with the Zn content of liver tissue, but negatively with serum one, at the time of maximum hepatocyte proliferative capacity. This study suggests that MT participates in hepatocyte replication after toxin-induced liver injury.


Sujet(s)
Lésions hépatiques dues aux substances/métabolisme , Régénération hépatique/effets des médicaments et des substances chimiques , Foie/métabolisme , Métallothionéine/biosynthèse , Thioacétamide/toxicité , Animaux , Lésions hépatiques dues aux substances/anatomopathologie , ADN/biosynthèse , ADN/effets des médicaments et des substances chimiques , Injections péritoneales , Foie/effets des médicaments et des substances chimiques , Foie/anatomopathologie , Régénération hépatique/physiologie , Mâle , Index mitotique/effets des médicaments et des substances chimiques , Rats , Rat Wistar , Thioacétamide/administration et posologie , Thymidine/métabolisme , Thymidine kinase/métabolisme , Zinc/sang
7.
Neuroendocrinology ; 69(5): 331-8, 1999 May.
Article de Anglais | MEDLINE | ID: mdl-10343174

RÉSUMÉ

Stressful stimuli are known to affect glucocorticoid receptor (GR) mRNA levels in the rat brain. The aim of this study was to examine the duration of chronic stress-induced changes in GR gene expression in the male rat hippocampus and cerebellum. By using in situ hybridization histochemistry, we detected a statistically significant down-regulation of GR mRNA both in the hippocampus and in the cerebellum of rats stressed for 8, 10 and 14 days. The same degree of down-regulation could also be detected in the above brain areas of rats stressed for 14 days and left undisturbed for 48 h or 8 days after stress. To examine the effects of subsequent stressors on the expression of down-regulated GR mRNA in the hippocampus of chronically stressed rats, we determined, by Northern blotting, GR mRNA levels in the hippocampi of rats stressed for 14 days and subsequently exposed to either short- or long-duration stressors. The down-regulated levels of GR mRNA remained practically unaffected when a subsequent new stressor was applied. Our results show that chronic stress-induced down-regulation of GR mRNA in the rat brain can be extended for periods longer than the initial/causative stimulus, irrespective of the presence of a novel stimulus.


Sujet(s)
Chimie du cerveau/physiologie , Régulation de l'expression des gènes/physiologie , Récepteurs aux glucocorticoïdes/biosynthèse , Récepteurs aux glucocorticoïdes/génétique , Stress psychologique/métabolisme , Animaux , Technique de Northern , Cervelet/métabolisme , Maladie chronique , Corticostérone/sang , Rétroaction/physiologie , Hippocampe/métabolisme , Axe hypothalamohypophysaire/physiologie , Hybridation in situ , Mâle , Dosage radioimmunologique , Rats , Rat Wistar , Natation/psychologie
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE